Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 661 AL 675

Gut Microbiota and Immunotherapy for Alzheimer's Disease

Dai CL, Liu F, Iqbal K, Gong CX.

Int J Mol Sci. 2022 Dec 3;23(23):15230. doi: 10.3390/ijms232315230.

Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets

Hamzé R, Delangre E, Tolu S, Moreau M, Janel N, Bailbé D, Movassat J.

Int J Mol Sci. 2022 Dec 4;23(23):15287. doi: 10.3390/ijms232315287.

Ferroptosis: a potential therapeutic target for Alzheimer's disease

Yang L, Nao J.

Rev Neurosci. 2022 Dec 15;34(5):573-598. doi: 10.1515/revneuro-2022-0121. Print 2023 Jul 26.

Modelling Alzheimer's disease using human brain organoids: current progress and challenges

Yanakiev M, Soper O, Berg DA, Kang E.

Expert Rev Mol Med. 2022 Dec 15;25:e3. doi: 10.1017/erm.2022.40.

The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course

Perani D.

Brain. 2022 Dec 19;145(12):4157-4159. doi: 10.1093/brain/awac432.

Lecanemab for Alzheimer's disease

Walsh S, Merrick R, Richard E, Nurock S, Brayne C.

BMJ. 2022 Dec 19;379:o3010. doi: 10.1136/bmj.o3010.

Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer's disease: protocol for the ExPlas study

Tari AR, Berg HH, Videm V, Bråthen G, White LR, Røsbjørgen RN, Scheffler K, Dalen H, Holte E, Haberg AK, Selbaek G, Lydersen S, Duezel E, Bergh S, Logan-Halvorsrud KR, Sando SB, Wisløff U.

BMJ Open. 2022 Sep 6;12(9):e056964. doi: 10.1136/bmjopen-2021-056964.

A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementias

Mafi JN, Walling AM, Villaflores C, Vangala S, Sorensen A, Cheng E, Turner A, Trutner Z, Cheng G, Arbanas JC, Waterman B, Shu S, Goldstein N, Sarkisian C.

PLoS One. 2022 Dec 20;17(12):e0277409. doi: 10.1371/journal.pone.0277409. eCollection 2022.

Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study

Huang CY, Hu CJ, Huang LK, Chang EH.

J Clin Pharm Ther. 2022 Dec;47(12):2074-2082. doi: 10.1111/jcpt.13752. Epub 2022 Aug 10.

Inflammation context in Alzheimer's disease, a relationship intricate to define

Novoa C, Salazar P, Cisternas P, Gherardelli C, Vera-Salazar R, Zolezzi JM, Inestrosa NC.

Biol Res. 2022 Dec 23;55(1):39. doi: 10.1186/s40659-022-00404-3.

PICALM and Alzheimer's Disease: An Update and Perspectives

Ando K, Nagaraj S, Küçükali F, de Fisenne MA, Kosa AC, Doeraene E, Lopez Gutierrez L, Brion JP, Leroy K.

Cells. 2022 Dec 10;11(24):3994. doi: 10.3390/cells11243994.

Astrocytic MicroRNAs and Transcription Factors in Alzheimer's Disease and Therapeutic Interventions

Nassar A, Kodi T, Satarker S, Chowdari Gurram P, Upadhya D, Sm F, Mudgal J, Nampoothiri M.

Cells. 2022 Dec 17;11(24):4111. doi: 10.3390/cells11244111.

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease

Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T, Verdile G.

Int J Mol Sci. 2022 Dec 13;23(24):15811. doi: 10.3390/ijms232415811.

Molecular Mechanisms of Alzheimer's Disease III

Macreadie IG.

Int J Mol Sci. 2022 Dec 14;23(24):15876. doi: 10.3390/ijms232415876.

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer's Disease

Rosenberry TL, Zhou HX, Stagg SM, Paravastu AK.

Molecules. 2022 Dec 12;27(24):8804. doi: 10.3390/molecules27248804.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias